Primary angiosarcoma of the breast is an extremely rare tumour with a difficult diagnosis and poor prognosis. We report a case of primary breast angiosarcoma diagnosed in the pathology department of the University Hospital of Oujda. An analysis of the epidemiological, diagnostic and therapeutic aspects of this type of tumour is made in this manuscript. Mastectomy is the standard treatment; the place of radiotherapy and chemotherapy is not well established. We report a case of a 18-year-old woman having an infectious symptomatology of the right breast for which she received an anti-infectious therapy inducing regression of inflammatory symptoms presented with a quick growing mass. Initial core needle biopsy showed a malignant vascular proliferation. The patient underwent a mastectomy. The tumor histology showed papillary formations and vascular structures lined by atypical cells with hyperchromatic nucleus and eosinophilic cytoplasm. The tumor cells expressed CD34 and CD31 but were negative for cytokeratin. The diagnosis of angiosarcoma grade I was made. The patient is now receiving chemotherapy. She is still alive.
Introduction
Angiosarcomas of the breast are very rare malignant tumours accounting for less than 0.05% [1] of all breast conjunctive vascular tumours. They are characterized by a high malignity and a fast growth rate [2] and evolve to rapid local recurrence and the appearance of visceral metastases. The diagnosis is essentially based on the histological assessment of the excised sample. The treatment is based on simple mastectomy. Our work is based on a case report with a review of the literature and aims to analyse the epidemiological, diagnostic and therapeutic aspects of this disease.
Patient and observation
An 18 year-old woman referred having an infectious symptomatology of the right breast 5 months ago for which she received an antiinfectious therapy inducing regression of inflammatory symptoms presented with a quick growing mass involving the two inferior quadrants of the right breast, but did not consult any doctor until it reached 10cm in its size. She had no history of breast trauma and no breast cancer in her family. An ultrasound of the right breast was 
Discussion
Primary angiosarcoma represents 0.05% of all mammary tumours and 8% of breast sarcomas [1, 3] . It occurs especially in women having an age between 30 and 40 years. The median survival term is typically 24 months with a five-year recurrence-free survival rate of only 33% [4] . Prognostic factors are the histological type, grade and size of the tumour as well as the involvement of surgical section margins [5] . The factors involved in carcinogenesis are exposure to vinyl chloride, arsenic and thorostat, foreign body-induced chronic irritation and the notion of localized trauma [6] . The primary breast angiosarcoma must be differentiated from radiotherapy induced mammary angiosarcoma. Clinically, the lesion always measures more than 2cm and presents as a painless nodule. Zellek et al found that the size of the tumour is correlated with the 10-year recurrence-free survival rate and that the prognosis is particularly unfavourable when the tumour size is greater than 10cm [7] . The skin may look purplish, reddish or angiomatous. Lymph nodes involvement is very rare (0 to 5% of cases) [8] . The radiologic findings are not specific.
Mammography can reveal a dense, often calcified, well circumscribed mass, with sometimes a focal asymmetry of density [9] . On ultrasound examination, it can appear as a heterogeneous mass with liquid areas related to necrotic and haemorrhagic changes [10] . It can also appear as a heterogeneous area of different echogenicity without any real mass [9] . The Doppler proves the hypervascular character of the tumour. MRI finds a heterogeneous low-and high-signal intensity mass respectively in T1 and T2 weighted sequences. Sometimes, T1-weighted MRI shows high-signal intensity areas corresponding to haemorrhagic zones or venous lakes [11] . The enhancement depends on the grade of the tumour. Recently, Itakura et al [12] have demonstrated the overexpression of vascular endothelial growth factor (VEGF-A) and VEGFR-1 in different subtypes of angiosarcomas. The standard treatment is total mastectomy [13, 14] . The assessment of the resection margins is fundamental and is the main predictor of local recurrence. Axillary lymph nodes dissection is useless except in cases of palpable lymph nodes since lymphatic spreading is rare [6] . Adjuvant chemotherapy is disappointing, but a benefit in terms of overall survival and recurrence-free survival has been found for high-grade angiosarcomas [15] . One of the therapeutic perspectives is targeted therapy, using anti-growth factor antibodies. The exploitation of VEGF-A and VEGF-C and its VEGF-R1 receptor, the main vascular growth factor, offers an interesting therapeutic target for inhibiting angiogenesis [16] .
Conclusion
Our case enabled us is to recall the characteristics of this rare tumour that can occur in a patient with no history of irradiation. Its prognosis is particularly severe and requires early diagnosis and rapid treatment. 
